Zymeworks Inc (ZYME)
8.26
+0.15
(+1.85%)
USD |
NASDAQ |
Apr 26, 14:13
Zymeworks Shareholders Equity (Quarterly): 464.81M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 464.81M |
September 30, 2023 | 424.34M |
June 30, 2023 | 448.92M |
March 31, 2023 | 473.54M |
December 31, 2022 | 492.96M |
September 30, 2022 | 179.76M |
June 30, 2022 | 222.28M |
March 31, 2022 | 282.44M |
December 31, 2021 | 249.09M |
September 30, 2021 | 278.93M |
June 30, 2021 | 321.47M |
March 31, 2021 | 377.14M |
December 31, 2020 | 409.92M |
September 30, 2020 | 432.35M |
June 30, 2020 | 491.25M |
Date | Value |
---|---|
March 31, 2020 | 522.42M |
December 31, 2019 | 245.68M |
September 30, 2019 | 309.52M |
June 30, 2019 | 334.02M |
March 31, 2019 | 170.01M |
December 31, 2018 | 180.49M |
September 30, 2018 | 169.67M |
June 30, 2018 | 186.46M |
March 31, 2018 | 94.53M |
December 31, 2017 | 116.43M |
September 30, 2017 | 82.58M |
June 30, 2017 | 96.93M |
March 31, 2017 | -8.986M |
December 31, 2016 | 9.002M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
179.76M
Minimum
Sep 2022
522.42M
Maximum
Mar 2020
366.36M
Average
377.14M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
Emergent BioSolutions Inc | 649.30M |
MariMed Inc | 71.56M |
Viemed Healthcare Inc | 113.90M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 580.88M |
Total Liabilities (Quarterly) | 116.07M |
Current Ratio | 7.405 |